The ultrastructural complexities of human mast cells are reviewed. Numerous investigators have provided ultrastructural descriptions of human mast cells in a variety of tissues in situ. We have reviewed these contributions and provide here unified information necessary for the recognition of the variable images presented by human mast cells and the substructural patterns of their granules. These studies in aggregate provide sufficient and necessary morphologic information for the identification of human mast cells found in tissues as contrasted with the necessary ultrastructural criteria for the identification of human basophilic leukocytes present either in bone marrow, peripheral blood, or tissues. Recent technical advances have provided rich sources of isolated, purified human mast cells from several organ sites. We have studied isolated, purified human lung mast cells in depth and present a review of these studies. Specifically, these in vitro studies of human mast cells have made possible the delineation of morphologic criteria for the distinction between two important subcellular organelles in human mast cells--secretory granules and lipid bodies. These organelles differ in structure, in content, in mechanism(s) of formation, in behavior during degranulation, and in behavior during recovery from degranulation. Secretory granules and their associated performed mediator(s) of inflammation are released together from appropriately stimulated mast cells. Lipid bodies contain large amounts of arachidonic acid. Ultrastructural autoradiographic analysis and biochemical determination of secreted, labeled products of arachidonic acid oxygenation by stimulated human mast cells demonstrate the release of small amounts of these labeled products in the same time course. We used an ultrastructural, morphometric, organelle aggregate volume analysis to show that the mechanism(s) of generation of human mast cell scroll granules differed from the mechanism of generation of lipid bodies. The morphologic kinetics of anaphylactic degranulation in vitro were correlated with histamine release kinetics in replicate samples of isolated, purified human lung mast cells. This noncytotoxic process is characterized by sequential morphologic changes. These include initially the swelling and alteration of intragranular materials, followed by granule membrane fusions to form elongated cytoplasmic degranulation channels filled with altered matrix materials. These closed channels open to the cells' surface through multiple narrow pores at peak release values for histamine. The aggregate volume of cytoplasmic granules decreases dramatically, whereas there is no significant changes i
本文综述了人类肥大细胞的超微结构复杂性。众多研究者对多种组织原位的人类肥大细胞进行了超微结构描述。我们回顾了这些研究成果,并在此提供识别人类肥大细胞呈现的多样图像及其颗粒亚结构模式所需的统一信息。这些研究汇总起来,为识别组织中发现的人类肥大细胞提供了充分且必要的形态学信息,这与识别存在于骨髓、外周血或组织中的人类嗜碱性白细胞所需的超微结构标准形成对比。近期的技术进步为从多个器官部位分离、纯化人类肥大细胞提供了丰富来源。我们深入研究了分离、纯化的人类肺肥大细胞,并对这些研究进行了综述。具体而言,这些对人类肥大细胞的体外研究使得描绘人类肥大细胞中两种重要亚细胞器——分泌颗粒和脂体之间差异的形态学标准成为可能。这些细胞器在结构、内容物、形成机制、脱颗粒过程中的行为以及脱颗粒恢复过程中的行为均有所不同。分泌颗粒及其相关的预形成炎症介质从适当刺激的肥大细胞中一起释放。脂体含有大量花生四烯酸。通过对受刺激的人类肥大细胞分泌的花生四烯酸氧化标记产物进行超微结构放射自显影分析和生化测定,结果表明在相同的时间进程中会释放少量这些标记产物。我们采用超微结构、形态计量学的细胞器聚集体体积分析方法,以表明人类肥大细胞卷轴状颗粒的生成机制与脂体的生成机制不同。体外过敏反应性脱颗粒的形态动力学与分离、纯化的人类肺肥大细胞重复样本中的组胺释放动力学相关。这个无细胞毒性的过程具有一系列形态学变化特征。这些变化最初包括颗粒内物质的肿胀和改变,随后颗粒膜融合形成充满改变的基质材料的细长细胞质脱颗粒通道。这些封闭通道在组胺释放峰值时通过多个狭窄孔向细胞表面开放。细胞质颗粒的聚集体体积显著减小,而……没有显著变化